Use of gene expression profiling to identify responsive patients treated with carboplatin (Carb), paclitaxel (Pac), and everolimus as first-line treatment for cancer of unknown primary (CUP): NCCTG N0871 (Alliance)
- Citation:
- J Clin Oncol vol 31 (15 suppl) abstr 2562
- Meeting Instance:
- ASCO 2013
- Year:
- 2013
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2314
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- M. Goetz N. Foster J. Meyers P. Steen D. Visscher H. Yoon R. Pillai D. Prow C. Reynolds B. Marchello R. Mowat B. Mattar C. Erlichman
- Networks:
- Study
- NCCTG-N0871
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: